{"id":5794,"text":"Yerba Maté (YM), has become a popular herb ingested for enhancing metabolic health and weight-loss outcomes.","label":[[0,15,"Herb name"]],"Comments":[]}
{"id":5795,"text":"No studies have tested the combined metabolic, satiety, and psychomotor effects of YM during exercise.","label":[[83,86,"Herb name"]],"Comments":[]}
{"id":5796,"text":"We tested whether YM ingestion affects fatty acid oxidation (FAO), profile of mood state score (POMS), and subjective appetite scale (VAS), during prolonged moderate exercise.","label":[[18,21,"Herb name"],[38,65,"Parameter"],[106,138,"Parameter"]],"Comments":[]}
{"id":5797,"text":"Twelve healthy active females were randomized to ingest either 2 g of YM or placebo (PLC) in a repeated-measures design.","label":[[0,29,"Cohort"],[7,15,"Pathology"],[22,30,"Sex"],[62,67,"Amount"],[70,73,"Herb name"]],"Comments":[]}
{"id":5798,"text":"Participants rested for 120 min before performing a 30-min cycling exercise corresponding to individuals’ crossover point intensity (COP).","label":[[24,32,"Duration"]],"Comments":[]}
{"id":5799,"text":"FAO, determined using indirect calorimetry, was significantly higher during the 30-min exercise in YM vs. PLC (0.21 ± 0.07 vs. 0.17 ± 0.06 g\/min, p < 0.05).","label":[[0,3,"Parameter"],[99,102,"Herb name"]],"Comments":[]}
{"id":5800,"text":"VAS scores for hunger, prospective eating, and desire to eat were all reduced (p < 0.05).","label":[[0,10,"Parameter"]],"Comments":[]}
{"id":5801,"text":"Whereas, POMS measures of focus, energy, and concentration were all increased (p < 0.05).","label":[],"Comments":[]}
{"id":5802,"text":"There was no significant time-effect for any of the measured variables, nor was there any interaction effects between YM treatment and time.","label":[[118,121,"Herb name"]],"Comments":[]}
{"id":5803,"text":"Combining YM intake with prolonged exercise at targeted ”fat-loss”’ intensities augments FAO and improves measures of satiety and mood state.","label":[[10,13,"Herb name"],[89,92,"Parameter"]],"Comments":[]}
{"id":5804,"text":"Such positive combined metabolic, satiety, and psychomotor effects may provide an important role for designing future fat and weight-loss lifestyle interventions.","label":[],"Comments":[]}
{"id":5805,"text":"Nutritional and exercise lifestyle strategies are primary tools for weight and fat loss to prevent major health risks and lifestyle diseases such as obesity, diabetes, and cardiovascular disease.","label":[[149,156,"Pathology"],[158,166,"Pathology"],[172,194,"Pathology"]],"Comments":[]}
{"id":5806,"text":"The effectiveness of healthy lifestyle strategies can be maximized with a variety of nutritional aids in the form of functional foods and naturally available herbal ingredients [1,2].","label":[],"Comments":[]}
{"id":5807,"text":"Yerba Maté (YM), the plant Ilex paraguariensis, is traditionally consumed in many South American regions, but its popularity is increasing in North America, Europe, and other regions worldwide [3].","label":[[0,15,"Herb name"],[26,46,"Herb name"]],"Comments":[]}
{"id":5808,"text":"Several anti-atherogenic and weight-loss properties have been associated with the regular consumption of YM [4], including anti-oxidation, vasodilation, reduction in blood lipids, and other anti-mutagenic and anti-glycation benefits [5,6,7,8,9].","label":[[105,108,"Herb name"]],"Comments":[]}
{"id":5809,"text":"These health properties have been attributed to several naturally-present bioactive ingredients, which have been detected in YM including polyphenols and caffeoyl derivatives (caffeic acid, chlorogenic acid, 3,4-Dicaffeoylquinic acid, 4,5-Dicaffeoylquinic acid and 3,5-Dicaffeoylquinic acid), phytosterols, saponins, some amino acids, vitamins, and minerals [4,5].","label":[[125,128,"Herb name"],[138,150,"Herb name"],[154,163,"Herb name"],[176,188,"Herb name"],[189,206,"Herb name"],[208,233,"Herb name"],[234,260,"Herb name"],[265,290,"Herb name"],[293,305,"Herb name"],[307,315,"Herb name"]],"Comments":[]}
{"id":5810,"text":"Metabolic functions of YM components are thought to be responsible for reductions in serum cholesterol, serum triglycerides, and glucose concentrations; and an improved glycemic control and lipid profile in in high-fat fed mice [7], reduced body fat mass, and distribution and reduced waist to hip ratio in humans, all shown following YM ingestion [10,11].","label":[[23,26,"Herb name"],[85,103,"Parameter"],[104,123,"Parameter"],[129,151,"Parameter"],[190,203,"Parameter"],[335,338,"Herb name"]],"Comments":[]}
{"id":5811,"text":"Recent findings have also indicated that YM metabolic properties may be combined with positive psychomotor and appetite control effects, which complement the YM fat-loss promoting properties.","label":[[41,44,"Herb name"],[158,161,"Herb name"]],"Comments":[]}
{"id":5812,"text":"Such effects include suppressed appetite through an increased expression of glucagon-like peptide-1 (GLP-1) and delayed gastric emptying, as seen in mice studies [12,13], and increased ghrelin up to 4.2-fold in rat models following YM ingestion [14].","label":[[75,108,"Target"],[120,136,"Parameter"],[148,161,"Study"],[185,193,"Target"],[232,235,"Herb name"]],"Comments":[]}
{"id":5813,"text":"A trend towards increased satiety, reduced hunger, and improved mood state has also been found using visual analogue scale in human participants who ingested YM combined with other fat-loss ingredients [15,16].","label":[[158,161,"Herb name"]],"Comments":[]}
{"id":5814,"text":"The reported psychomotor effects include improved total mood disturbance score [15], increased focus, alertness and energy, and decreased fatigue in habitual caffeine consumers [16].","label":[[158,167,"Herb name"]],"Comments":[]}
{"id":5815,"text":"Modifying behavioral factors of mood state and appetite control is considered essential for effective weight-loss lifestyle interventions [17,18,19].","label":[],"Comments":[]}
{"id":5816,"text":"Consequently, indications of the positive YM effects combined with exercise on those outcomes should be further investigated, especially given the known positive effects of exercise on mood state and mental health [20].","label":[[42,45,"Herb name"]],"Comments":[]}
{"id":5817,"text":"Along with the nutritional metabolic weight and fat-loss benefits, exercise is known to stimulate fat metabolism, and reverse associated metabolic health risks.","label":[],"Comments":[]}
{"id":5818,"text":"YM effects on thermogenesis has been suggested to promote fat-loss by influencing indirect calorimetry measures such as energy expenditure (EE), fatty acid oxidation (FAO), and respiratory exchange ratio (RER) in resting healthy obese participants [21].","label":[[0,3,"Herb name"],[119,143,"Parameter"],[145,171,"Parameter"],[177,209,"Parameter"],[221,229,"Pathology"]],"Comments":[]}
{"id":5819,"text":"However, little is known about such YM metabolic effects during exercise.","label":[[36,39,"Herb name"]],"Comments":[]}
{"id":5820,"text":"Our recent work has shown that YM favors FAO as a fuel source during exercise, when either ingested as a single ingredient [22] or combined with other fat-loss compounds in a multi-ingredient supplement [15].","label":[[31,34,"Herb name"],[41,45,"Parameter"]],"Comments":[]}
{"id":5821,"text":"In Alkhatib, 2014 it was found that 1 g of YM can induce an over 20% increase in FAO at the exercise intensity range of 40–70% of peak oxygen uptake ( Given our recent promising findings of YM acute effects on FAO during exercise intensities in the COP range [15,22], and the YM weight-loss postulated effects on satiety and mood state [13,22], our study is important to test whether and how YM affects FAO, satiety, and mood state during prolonged exercise at individuals’ COP intensities.","label":[[36,40,"Amount"],[43,46,"Herb name"],[81,84,"Parameter"],[190,193,"Herb name"],[210,214,"Parameter"],[276,279,"Herb name"],[392,395,"Herb name"],[403,406,"Herb name"]],"Comments":[]}
{"id":5822,"text":"This study aims to test the hypothesis that YM ingestion combined with steady state exercise at the COP intensities augments FAO, and improves the measures of satiety and mood state.","label":[[44,47,"Herb name"],[125,128,"Parameter"]],"Comments":[]}
{"id":5823,"text":"The study followed a double-blind repeated-measures crossover placebo-controlled design.","label":[[4,88,"Study"]],"Comments":[]}
{"id":5824,"text":"All tests were performed at similar laboratory environmental conditions controlling for air temperature, barometric pressure, and relative humidity.","label":[],"Comments":[]}
{"id":5825,"text":"The study was approved by the institution’s ethical committee.","label":[],"Comments":[]}
{"id":5826,"text":"All experimental procedures were carried out in accordance with the ethical guidelines of the World Medical Association Declaration of Helsinki.","label":[],"Comments":[]}
{"id":5827,"text":"All study participants provided their informed written consent and were given an explanation of the purpose of the research and experimental procedures.","label":[],"Comments":[]}
{"id":5828,"text":"Exclusion criteria were as follows.","label":[],"Comments":[]}
{"id":5829,"text":"(1) History of any cardiovascular or respiratory disease, hypertension, liver or kidney disease, musculoskeletal or neuromuscular or neurological disease, autoimmune disease, cancer, peptic ulcers or anemia; (2) Taking medications, including those for heart, pulmonary, thyroid, anti-hyperlipidemic, hypoglycemic, anti-hypertensive, endocrinologic, psychotropic, neuromuscular, neurological, or androgenic conditions, as well as a family history of heart problems, high blood pressure, and\/or stroke, and being pregnant or breastfeeding.","label":[[19,56,"Pathology"],[58,70,"Pathology"],[71,95,"Pathology"],[97,153,"Pathology"],[155,173,"Pathology"],[175,181,"Pathology"],[183,196,"Pathology"],[200,206,"Pathology"],[279,298,"Drug"],[314,331,"Drug"],[465,484,"Pathology"],[493,499,"Pathology"]],"Comments":[]}
{"id":5830,"text":"(3) Consuming any ergogenic aid or above habitual caffeine consumption rate (≥200 mg\/day) for at least six weeks prior to the study similarly to a previously used approach [16], based on all types of caffeinated beverages (coffee, energy drinks, soft drinks, caffeine supplements, or medications).","label":[[50,59,"Herb name"],[78,88,"Frequency"],[103,112,"Duration"]],"Comments":[]}
{"id":5831,"text":"Inclusion criteria included females, aged 18–40 years, habitually complete ≥150 min of moderate physical activity per week, BMI < 30.0 kg\/m Participants were physically active healthy women volunteers, and were recruited by convenient sampling.","label":[[28,35,"Sex"],[42,53,"Age"],[76,83,"Duration"],[124,128,"Parameter"],[128,140,"Amount"],[176,184,"Pathology"],[184,190,"Sex"]],"Comments":[]}
{"id":5832,"text":"A total of 12 females completed the study [Mean ± SD, age = 30.8 ± 7.3 years, stature: 167.2 ± 3.9 m, body mass: 61.5 ± 2.8 kg, BMI = 22.0 ± 1.1 kg\/m All participants reported to the Physiology Laboratory on three separate occasions followed by 3 h fasting state in the first session, and 10–12 h overnight fasting in the second and third sessions.","label":[[11,22,"Cohort"],[14,22,"Sex"],[60,76,"Age"],[128,132,"Parameter"],[134,149,"Amount"],[244,248,"Duration"],[289,296,"Duration"]],"Comments":[]}
{"id":5833,"text":"Each testing session (between 09:30 and 11:30 a.m.) was separated by at least three days within a two-week period.","label":[[77,88,"Duration"],[98,106,"Duration"]],"Comments":[]}
{"id":5834,"text":"Session one involved the participants being assessed for their body composition and exercise performance variables for all participants, including  Body composition was assessed using bioelectrical impedance scale, which also provides body weight, assessed to the nearest 0.1 kg (InBody version 720, Biospace, Seoul, Korea).","label":[],"Comments":[]}
{"id":5835,"text":"Height was assessed to the nearest 0.5 cm using a Stadiometer (Seca scales, Hamburg, Germany).","label":[],"Comments":[]}
{"id":5836,"text":"The baseline exercise protocol involved the participants completing an incremental exercise test using an electronically braked cycle ergometer (Lode, Excalibur Sport, Groningen, The Netherlands).","label":[],"Comments":[]}
{"id":5837,"text":"The saddle height and distance from the handlebar were recorded at the initial visit and re-applied in all subsequent visits.","label":[],"Comments":[]}
{"id":5838,"text":"Participants began cycling at 25 watts for three minutes and work rate increased by 25 watts every three minutes until volitional exhaustion.","label":[],"Comments":[]}
{"id":5839,"text":"The breath-by breath cardiorespiratory data of  Participants received the supplement immediately before resting for 120 min in a semi-recumbent position during which they remained awake, while not talking and limited their movement.","label":[[116,123,"Duration"]],"Comments":[]}
{"id":5840,"text":"At the end of the resting period, participants were transitioned to a cycle ergometer where they cycled continuously for 30 min at a workload pre-determined from their COP calculated during the baseline visit.","label":[[121,128,"Duration"]],"Comments":[]}
{"id":5841,"text":"The cadence for the exercise protocol was self-selected to fall within a range of 60–80 RPM for the two supplementation trials.","label":[],"Comments":[]}
{"id":5842,"text":"Appetite and satiety were measured using a visual analogue 100 mm scale (VAS), which recorded perceived hunger, fullness, desire to eat, and prospective food consumption [30].","label":[[59,65,"Amount"],[73,76,"Parameter"]],"Comments":[]}
{"id":5843,"text":"The scale was anchored at each end with the labels “not at all” (0 mm) and “extremely” (100 mm).","label":[],"Comments":[]}
{"id":5844,"text":"Subjects marked a line through the scale between the two extremes of the symptoms being rated which they considered to indicate the degree of the subjective feeling being rated.","label":[],"Comments":[]}
{"id":5845,"text":"VAS was completed prior to supplementation, every 30 min during the 120-min resting period, immediately post exercise (0 min), and 30 min post exercise.","label":[[0,4,"Parameter"],[68,75,"Duration"]],"Comments":[]}
{"id":5846,"text":"Profile of mood state (POMS) questionnaire [31] was used to assess participants’ mood state (perceived alertness, focus, energy, fatigue, and concentration).","label":[],"Comments":[]}
{"id":5847,"text":"Participants were asked to rate their perceived mood on a scale ranging between one and five for all five categories.","label":[],"Comments":[]}
{"id":5848,"text":"POMS questionnaires were completed prior to supplementation, every 30-min during the 120-min resting period, immediately post exercise, and 30-min post exercise.","label":[[85,92,"Duration"]],"Comments":[]}
{"id":5849,"text":"All data are presented as means and standard deviations.","label":[],"Comments":[]}
{"id":5850,"text":"FAO, CHO, EE, HR, POMS, and VAS were analyzed using two-way repeated measures ANOVA (YM × Time), with YM supplement as within factors, and six time points during 30-min for the exercise metabolic data (FAO, CHO, EE, HR) as between factors.","label":[[0,3,"Parameter"],[5,8,"Parameter"],[10,12,"Parameter"],[14,16,"Parameter"],[28,32,"Parameter"],[102,105,"Herb name"],[161,168,"Duration"],[202,205,"Herb name"],[207,210,"Herb name"],[212,214,"Herb name"],[216,218,"Herb name"]],"Comments":[]}
{"id":5851,"text":"Bonferroni post hoc test was applied to analyze the differences at each time point.","label":[],"Comments":[]}
{"id":5852,"text":"For VAS and POMS the measured time points were analyzed using two-way ANOVA (Treatment × Time) for both rest condition at time points (0, 30, 60, 90, and 120 min), and exercise condition immediately before supplementation (0-min), immediately before exercise (120-min), immediately after exercise (150-min), and post 30-min recovery following exercise (180-min).","label":[[4,8,"Parameter"],[12,17,"Parameter"],[260,267,"Duration"],[298,305,"Duration"],[353,360,"Duration"]],"Comments":[]}
{"id":5853,"text":"The area under the curve (AUC) was calculated using trapezoidal method, and was compared between the treatments using a paired t-test.","label":[[4,31,"Parameter"]],"Comments":[]}
{"id":5854,"text":"For all statistics SPSS IBM statistics V24 was used and the significance level was set at p < 0.05.","label":[],"Comments":[]}
{"id":5855,"text":"The exercise power output at the cross-over point (COP) determined during the baseline assessment was 50.8 ± 22.3 W corresponding to a relative exercise intensity of 37.5 ± 8.0%  The YM treatment elicited significantly higher FAO compared with PLC during the 30-min steady-state exercise (ANOVA treatment effects, p = 0.037), (Figure 1).","label":[[183,186,"Herb name"],[226,230,"Parameter"]],"Comments":[]}
{"id":5856,"text":"The difference was also affected by the time of exercise (ANOVA time effect p < 0.001).","label":[],"Comments":[]}
{"id":5857,"text":"The highest FAO difference was after 20 min (0.21 ± 0.07 vs. 0.17 ± 0.05 g\/min, p = 0.039), and 25 of exercise (0.22 ± 0.07 vs. 0.17 ± 0.06 g\/min, p = 0.015) for YM compared with PLC (Figure 1).","label":[[12,16,"Herb name"],[162,165,"Herb name"]],"Comments":[]}
{"id":5858,"text":"Calculating AUC showed a higher total AUC for FAO in YM than PLC (5.22 vs. 4.20, p < 0.001).","label":[[12,16,"Parameter"],[38,42,"Parameter"],[46,50,"Parameter"],[53,56,"Herb name"]],"Comments":[]}
{"id":5859,"text":"However, there was no significant interaction between YM treatment and exercise time.","label":[[54,57,"Herb name"]],"Comments":[]}
{"id":5860,"text":"CHO was not significantly different between the treatments, but there was a time effect (ANOVA time effects, p < 0.001) with the CHO initially increased and then decreased over exercise time in both treatments (Figure 2).","label":[[0,4,"Parameter"],[129,133,"Parameter"]],"Comments":[]}
{"id":5861,"text":"No interaction for CHO between treatment and time was found.","label":[[19,23,"Parameter"]],"Comments":[]}
{"id":5862,"text":"However, the total AUC for CHO was lower in YM than PLC (13.3 vs. 15.00, p < 0.001).","label":[[19,23,"Parameter"],[27,31,"Parameter"],[44,47,"Herb name"]],"Comments":[]}
{"id":5863,"text":"Total Energy Expenditure (TEE) was neither significantly affected by the treatment (YM vs. PLC) nor the exercise time (Figure 3).","label":[[0,31,"Parameter"],[84,87,"Herb name"],[91,94,"Drug"]],"Comments":[]}
{"id":5864,"text":"However, the total AUC for TEE was higher (85.60 vs. 82.13, p < 0.001) in YM than PLC.","label":[[19,23,"Parameter"],[27,31,"Parameter"],[74,77,"Herb name"]],"Comments":[]}
{"id":5865,"text":"HR was not different between the treatments, but the time had significant effects (p < 0.001), (Figure 4).","label":[],"Comments":[]}
{"id":5866,"text":"No interaction effects were found.","label":[],"Comments":[]}
{"id":5867,"text":"RPE, measured at three exercise time points, was also not affected between the treatments (YM vs. PLC) or exercise duration, nor was there any interaction effect between YM and exercise time (Figure 5).","label":[[91,94,"Herb name"],[170,173,"Herb name"]],"Comments":[]}
{"id":5868,"text":"There were significant treatment effects (YM vs. PLC) on VAS measures of Hunger (p = 0.019), Prospective eating (p = 0.022), and a trend towards a reduced desire to eat (p = 0.079) for exercise (Pre, immediately before, after, and 30 min post exercise).","label":[[42,45,"Herb name"],[57,61,"Parameter"]],"Comments":[]}
{"id":5869,"text":"There was no YM effect on fullness score.","label":[[13,16,"Herb name"]],"Comments":[]}
{"id":5870,"text":"The time effect was not significant for all VAS satiety measures, and there was no interaction between time and YM treatment (Table 1).","label":[[44,48,"Parameter"],[112,115,"Herb name"]],"Comments":[]}
{"id":5871,"text":"When analyzing the resting data only (immediately pre-ingestion 0 to 120 min rest duration), only prospective eating score was slightly reduced (p = 0.046) at YM treatment compared with PLC, but there were no significant YM treatment or rest time effects in any of the remaining VAS measures, nor were there any interaction effects (Table 1).","label":[[68,76,"Duration"],[159,162,"Herb name"],[221,224,"Herb name"]],"Comments":[]}
{"id":5872,"text":"YM significantly affected POMS measures following exercise by an increased focus (p = 0.022), energy (p = 0.008) and concentration (p = 0.003), and a trend towards an increased alertness (p = 0.066) in the YM treatment compared with PLC (Table 2).","label":[[0,3,"Herb name"],[206,209,"Herb name"],[233,237,"Drug"]],"Comments":[]}
{"id":5873,"text":"No effects were found for fatigue scores.","label":[[26,34,"Pathology"]],"Comments":[]}
{"id":5880,"text":"Targeting such intensities with exercise training enhances fat metabolism, and associated “fat-loss” metabolic health outcomes including increased insulin sensitivity [25], enhanced lipolysis and ability to oxidize lipids [32,33], and microvascular activity [26].","label":[[146,167,"Parameter"],[235,257,"Parameter"]],"Comments":[]}
{"id":5874,"text":"Exercise time had no effect on any of the POMS measures nor was there any interaction between treatment and time (Table 2).","label":[],"Comments":[]}
{"id":5875,"text":"When analyzing the resting data only (immediately pre-ingestion 0 to 120 min rest duration) no significant effects were found for YM treatment, rest duration, nor were there any interaction effects (Table 2).","label":[[68,76,"Duration"],[130,133,"Herb name"]],"Comments":[]}
{"id":5876,"text":"In this experiment, YM increased FAO during prolonged steady-state exercise and induced positive psychomotor mood state and satiety during and after exercise without affecting the exercise RPE.","label":[[20,23,"Herb name"],[33,37,"Parameter"]],"Comments":[]}
{"id":5877,"text":"Augmented FAO was approximately 23% higher in YM compared with PLC during 30 min of steady-state low-to-moderate intensity exercise corresponding to individuals’ COP intensity (Figure 1).","label":[[10,14,"Parameter"],[46,49,"Herb name"],[63,67,"Drug"]],"Comments":[]}
{"id":5878,"text":"This increase is comparable with 24% increase found during low to moderate exercise intensities determined using an incremental protocol in our previous study [22].","label":[],"Comments":[]}
{"id":5879,"text":"The present study extended previous findings by determining COP individually, and demonstrated that YM ingestion is effective in enhancing the impact of FAO at the targeted COP exercise intensities.","label":[[100,103,"Herb name"],[153,157,"Parameter"]],"Comments":[]}
{"id":5881,"text":"Therefore, YM augments such metabolic outcomes when combined with prolonged exercise at such given fat-loss intensities.","label":[[11,14,"Herb name"]],"Comments":[]}
{"id":5882,"text":"Previous studies in human participants have shown promising effects of YM ingestion on metabolic rate and RER acutely [21], and after 12 weeks of ingestion, on blood lipid metabolites in healthy obese participants [11,21].","label":[[71,74,"Herb name"],[134,143,"Duration"],[187,195,"Pathology"]],"Comments":[]}
{"id":5883,"text":"However, these metabolic effects were only tested at rest.","label":[],"Comments":[]}
{"id":5884,"text":"YM was also administered, with various metabolic efficacy, in various doses of ≈1 g of proprietary multi-ingredient thermogenic blends containing weight-loss ingredients such as YM and green tea extracts, caffeine anhydrous, guarana, yohimbine HCI, capsicum, ginger and bitter orange extracts, and other proprietary blends [16,22,34].","label":[[0,3,"Herb name"],[80,83,"Amount"],[178,181,"Herb name"],[184,195,"Herb name"],[205,223,"Herb name"],[225,232,"Herb name"],[234,247,"Herb name"],[249,257,"Herb name"],[259,266,"Herb name"],[270,284,"Herb name"]],"Comments":[]}
{"id":5885,"text":"In two separate studies conducted previously, we tested the exercise-dependent effects on FAO at various intensities with 1 g YM [22] or when YM combined with a proprietary thermogenic blend of 1.5 g dose [15].","label":[[90,94,"Parameter"],[121,126,"Amount"],[126,129,"Herb name"],[142,145,"Herb name"],[193,199,"Amount"]],"Comments":[]}
{"id":5886,"text":"Both studies used mixed gender samples and showed an augmented FAO during low-to-moderate intensity exercise of 24% and 26% in YM compared with PLC.","label":[[63,67,"Parameter"],[127,130,"Herb name"],[144,147,"Drug"]],"Comments":[]}
{"id":5887,"text":"This is close to the 23% found for FAO in this cohort of female participants, using a higher ingestion dose of 2 g (Figure 1).","label":[[35,39,"Parameter"],[57,64,"Sex"],[111,114,"Amount"]],"Comments":[]}
{"id":5888,"text":"The 38%  It is likely that active YM thermogenic ingredients work in synergy to promote lipolysis and augment FAO during exercise.","label":[[34,37,"Herb name"],[110,114,"Parameter"]],"Comments":[]}
{"id":5889,"text":"The metabolic effects include adrengenic effects and stimulated central nervous system associated with caffeine, anti-lipolytic, and hypocholesterolemic properties in chlorogenic acids (mono- and di-caffeolquinic acids) hydroxycinnamic acids (caffeic acid, quinic acid) and triterpenic saponins, and other minerals and vitamins [5].","label":[[103,111,"Herb name"]],"Comments":[]}
{"id":5890,"text":"Anti-oxidant compounds in YM such as flavonoids and polypheonols are common in other herbal teas and may affect nitric oxide levels, which have been shown to be effective in inducing vasodialatory effects [37] when combined with exercise [27,38].","label":[[26,29,"Herb name"],[37,48,"Herb name"],[52,65,"Herb name"]],"Comments":[]}
{"id":5891,"text":"Anti-oxidant compounds of YM have been recently attributed to accelerating muscle strength recovery 24 h after exercise, suggesting that YM favored the concentration of blood antioxidant compounds [39].","label":[[26,29,"Herb name"],[99,104,"Duration"],[137,140,"Herb name"]],"Comments":[]}
{"id":5892,"text":"Therefore, YM active ingredients may have played a synergetic role in the metabolic effects found during exercise.","label":[[11,14,"Herb name"]],"Comments":[]}
{"id":5893,"text":"However, further research is required to assess active ingredients of YM capsules and analyze their bioavailability following ingestion.","label":[[70,73,"Herb name"],[100,116,"Parameter"]],"Comments":[]}
{"id":5894,"text":"Favorable psychomotor effects on mood state and satiety are often expected outcomes of fat and weight-loss supplementation protocols.","label":[],"Comments":[]}
{"id":5895,"text":"However, several negative side effects were reported for common thermogenic supplements containing caffeine including jitteriness, mood swings, and headache [40].","label":[[26,39,"Pathology"],[99,108,"Herb name"],[118,129,"Pathology"],[131,142,"Pathology"],[148,157,"Pathology"]],"Comments":[]}
{"id":5896,"text":"It is suggested that these effects can be reduced with YM ingested with other ingredients compared with caffeine [22,40].","label":[[55,58,"Herb name"],[104,113,"Herb name"]],"Comments":[]}
{"id":5897,"text":"The present study found an improvement in almost all measures of POMS and VAS (Table 1).","label":[[74,78,"Parameter"]],"Comments":[]}
{"id":5898,"text":"In particular, there was an increased focus (p = 0.022), energy (p = 0.008) and concentration (p = 0.003) in the YM treatment compared with PLC, which was combined with no effects on fatigue scores.","label":[[113,116,"Herb name"],[140,143,"Drug"]],"Comments":[]}
{"id":5899,"text":"Interestingly, the RPE score was not different (Figure 5), suggesting that the positive psychomotor YM effects had no negative effects on the perception of effort and fatigue during exercise, which is important when considering adherence to prescribed exercise for weight loss and sport performance outcomes.","label":[[100,103,"Herb name"]],"Comments":[]}
{"id":5900,"text":"There was also a reduction in appetite VAS measures, especially for hunger (p = 0.019) and prospective eating (p = 0.022), (Table 1) following the YM ingestion compared with PLC.","label":[[39,43,"Parameter"],[147,150,"Herb name"],[174,177,"Drug"]],"Comments":[]}
{"id":5901,"text":"These YM appetite control effects are reported in humans for the first time, considering previous positive effects reported in animal models [13,14], and the recent report of appetite suppression following exercise in trained female participants [41].","label":[[6,9,"Herb name"],[226,233,"Sex"]],"Comments":[]}
{"id":5902,"text":"The reduced VAS appetite scores are also in line with previous results found when YM was combined with other multi-ingredients before and after moderate exercise at Fatmax intensities at 43%  HR response is a standard measurement for exercise intensity and training cardiovascular adaptations, but it was not significantly affected by YM ingestion (Figure 5).","label":[[12,31,"Parameter"],[82,85,"Herb name"],[335,338,"Herb name"]],"Comments":[]}
{"id":5903,"text":"Cardiovascular benefits for YM consumption have been reported using more sensitive biomarkers such as detecting an increase in vascular endothelium-dependent vasorelaxing activity in rats [43,44].","label":[[28,31,"Herb name"],[127,179,"Target"]],"Comments":[]}
{"id":5904,"text":"Such microvascular measurements have been shown to be sensitive to the exercise-dependent effects in human lifestyle interventions [26].","label":[],"Comments":[]}
{"id":5905,"text":"Perhaps HR monitoring is insufficient to detect vascular responses associated with combining YM ingestion with exercise, and future research could determine more sensitive macro- and microvascular health effects associated with YM ingestion during exercise, especially when combined with detecting YM metabolic effects found in the present study.","label":[[93,96,"Herb name"],[228,231,"Herb name"],[298,301,"Herb name"]],"Comments":[]}
{"id":5906,"text":"Although there was not significance for all variables, the significant increase in FAO is mathematically accounted for by combined non-significant reductions in glucose oxidation and non-significant elevated TEE for YM (Figure 3).","label":[[83,87,"Parameter"],[161,178,"Parameter"],[208,212,"Parameter"],[216,219,"Herb name"]],"Comments":[]}
{"id":5907,"text":"The estimates are approximately 0.35 kcal\/min greater FAO, and 0.23 reduced CHO with 0.14 kcal\/min greater TEE, and with a corresponding significant YM on the calculated total AUC for FAO, CHO, and TEE (p < 0.001).","label":[[31,45,"Amount"],[54,57,"Parameter"],[76,80,"Parameter"],[85,98,"Amount"],[107,110,"Parameter"],[149,152,"Herb name"],[176,180,"Parameter"],[184,187,"Parameter"],[189,192,"Parameter"],[198,202,"Parameter"]],"Comments":[]}
{"id":5908,"text":"It is unclear whether there are additional YM effects on glucose and adipose tissue levels not determined in this study [45].","label":[[43,46,"Herb name"]],"Comments":[]}
{"id":5909,"text":"We used indirect calorimetry methodology to estimate metabolic variables, so perhaps future studies could use different techniques to estimate YM effects on different body compartments, tissues, and metabolites by including in vitro and muscle biopsy methods.","label":[[143,146,"Herb name"]],"Comments":[]}
{"id":5910,"text":"With respect to the gender-specific effects on metabolism, females’ FAO during exercise is known to be higher compared to men [46], possibly due to higher total body fat percentage, fitness level, and exercise modality [47].","label":[[68,72,"Parameter"]],"Comments":[]}
{"id":5911,"text":"The BF% data indicated all females who took part were at the lower BF% percentile, indicating that they were physically active, with higher  Although the positive effects of YM on fat-loss outcomes during exercise are found only in single trials, future research could test the longitudinal YM effectiveness, especially when combining regular exercise training with YM treatment.","label":[[27,35,"Sex"],[174,177,"Herb name"],[291,294,"Herb name"],[366,369,"Herb name"]],"Comments":[]}
{"id":5912,"text":"This is important for lifestyle disease prevention, given the effectiveness found for YM alone as treatment for human obesity, found in recent randomized controlled trials [10,11].","label":[[86,89,"Herb name"],[143,171,"Study"]],"Comments":[]}
{"id":5913,"text":"The present study used COP as an effective and a well-established “fat burning” exercise training intensity [24,32,33], but other established concepts in a similar domain, such as Fatmax intensity, can also be effective as we previously demonstrated [15].","label":[],"Comments":[]}
{"id":5914,"text":"The debate concerning a relevant exercise training intensity to maximize “fat-loss” is beyond the scope of this study, and has been sufficiently discussed elsewhere [23,24,28,32,33].","label":[],"Comments":[]}
{"id":5915,"text":"Most of the studies cited within the present study have attributed their YM ingestion effects to the several bioactive ingredients and only some of those studies have analyzed YM supplement (e.g., total phenolic compounds, caffeine, and saponins) for such ingredients as part of their protocol [39].","label":[[73,76,"Herb name"],[176,179,"Herb name"],[203,221,"Herb name"],[223,231,"Herb name"],[237,245,"Herb name"]],"Comments":[]}
{"id":5916,"text":"However, methodological differences in terms of YM supplement preparations and methods used should be considered for such comparisons.","label":[[48,51,"Herb name"]],"Comments":[]}
{"id":5917,"text":"For example, the encapsulated ground green YM leaves used in this study is different from lyophilized YM extracts brewed and used elsewhere [39].","label":[[45,46,"Herb name"],[102,104,"Herb name"]],"Comments":[]}
{"id":5918,"text":"Also, the study did not specifically analyze the polyphenolic content of YM, and only relied on the supplier’s certificate of analysis for YM content, which makes it difficult to attribute findings to a single YM ingredient.","label":[[73,75,"Herb name"],[139,142,"Herb name"],[210,213,"Herb name"]],"Comments":[]}
{"id":5919,"text":"Nonetheless, it is reasonable to infer synergetic effects of naturally-occurring YM ingredients but, from a biochemical point of view, performing phytochemical analysis on the supplement is important for future research.","label":[[81,84,"Herb name"]],"Comments":[]}
{"id":5920,"text":"It would be also interesting to follow up with testing the YM active ingredients’ bioavailability post ingestion.","label":[[59,62,"Herb name"],[82,98,"Parameter"]],"Comments":[]}
{"id":5921,"text":"Limited research has been conducted in humans prior to this study [10,11,22], which makes it difficult to confirm some parallels made with animal models when explaining YM mechanisms.","label":[[169,172,"Herb name"]],"Comments":[]}
{"id":5922,"text":"Nonetheless, our findings in human participants extend previous knowledge and demonstrate novel applications of YM for human metabolic health.","label":[[112,115,"Herb name"]],"Comments":[]}
{"id":5923,"text":"Combining YM ingestion with exercise prescription at COP training intensities improves FAO, measures of satiety and mood state compared with exercise alone.","label":[[10,13,"Herb name"],[87,90,"Parameter"]],"Comments":[]}
{"id":5924,"text":"The underlying mechanisms of such effects require further investigation.","label":[],"Comments":[]}
{"id":5925,"text":"The combined exercise and YM effects on metabolic, psychomotor, and appetite control outcomes are essential for designing an optimized lifestyle prevention for metabolic health and exercise fat-loss outcomes.","label":[[26,29,"Herb name"]],"Comments":[]}
{"id":5926,"text":"Future research should test the longitudinal effectiveness of YM and exercise for metabolic health outcomes.","label":[[62,65,"Herb name"]],"Comments":[]}
{"id":5927,"text":"The authors would like to thank the volunteer participants and the laboratory technicians at Sheffield Hallam University for their help during data collection phase.","label":[],"Comments":[]}
{"id":5928,"text":"A.A. conceived the idea, designed the study, supervised data collection, analyzed the data, and wrote the full manuscript.","label":[],"Comments":[]}
{"id":5929,"text":"R.A. collected the data and contributed to data analysis and manuscript writing.","label":[],"Comments":[]}
{"id":5930,"text":"Both authors approved the final manuscript version.","label":[],"Comments":[]}
{"id":5931,"text":"The authors declare no conflict of interest.","label":[],"Comments":[]}
{"id":5932,"text":"Fatty Acid Oxidation (FAO) during exercise in Yerba Mate (YM) vs. placebo (PLC).","label":[[0,26,"Parameter"],[46,62,"Herb name"],[65,79,"Drug"]],"Comments":[]}
{"id":5933,"text":"ANOVA treatment effect (p < 0.05).","label":[],"Comments":[]}
{"id":5934,"text":"* Significantly higher in YM compared with PLC.","label":[[26,29,"Herb name"],[43,46,"Drug"]],"Comments":[]}
{"id":5935,"text":"Carbohydrate oxidation during exercise in Yerba Mate (YM) vs. placebo (PLC), (p > 0.05).","label":[[0,22,"Parameter"],[41,57,"Herb name"],[61,75,"Drug"]],"Comments":[]}
{"id":5936,"text":"Total Energy expenditure during exercise in Yerba Mate (YM) vs. placebo (PLC).","label":[[44,60,"Herb name"],[64,77,"Drug"]],"Comments":[]}
{"id":5937,"text":"Heart rate response during exercise in Yerba Mate (YM) vs. placebo (PLC).","label":[[39,54,"Herb name"],[59,72,"Drug"]],"Comments":[]}
{"id":5938,"text":"Rate of perceived exertion during exercise in Yerba Mate (YM) vs. placebo (PLC).","label":[[45,61,"Herb name"],[66,80,"Drug"]],"Comments":[]}
{"id":5939,"text":"Satiety results of Visual Analogue Scale (VAS) for Yerba Mate (YM) and placebo (PLC) treatment at different time points, at rest (0–120 min), exercise (120–150 min), and post exercise (180 min).","label":[[18,46,"Parameter"],[50,66,"Herb name"],[71,84,"Drug"],[132,139,"Duration"],[152,163,"Duration"],[185,192,"Duration"]],"Comments":[]}
{"id":5940,"text":"Results displayed as Mean ± SD.","label":[],"Comments":[]}
{"id":5941,"text":"Profile of Mood State (POMS) results for Yerba Mate (YM) and placebo (PLC) treatments at different time points, at rest (0–120 min), exercise (120–150 min), and post exercise (180 min).","label":[[41,56,"Herb name"],[61,75,"Drug"],[123,130,"Duration"],[143,154,"Duration"],[176,183,"Duration"]],"Comments":[]}
{"id":5942,"text":"Results displayed as Mean ± SD.","label":[],"Comments":[]}
